EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1

Muhammad Naveed, Urooj Ali, Tariq Aziz, Muhammad Junaid Rasool, Adil Ijaz, Metab Alharbi, Mousa Essa Alharbi, Abdulrahman Alshammari, Abdullah F Alasmari

Acta Biochimica Polonica · 2023

DOI: 10.18388/abp.2020_6696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica Polonica, 2023. Verfasst von Muhammad Naveed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Life Sciences, University of Central Punjab, Lahore-54590, Pakistan. Hauptthemen laut MEDLINE: HIV-1. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There have been substantial advances in HIV research over the past three decades, but we are still far from our goal of eliminating HIV-1 infection entirely. Numerous ever-evolving antigens are produced as a result of HIV-1’s genetic variability. Developing an effective vaccination is challenging because of the structural properties of the viral envelope glycoprotein that obscure conserved receptor-binding sites and the presence of carbohydrate moieties that prevent antibodies from reaching potential epitopes. To work on an HIV-specific vaccine, this study identified 5 HIV-surface proteins, from the literature, to screen potential epitopes and construct an mRNA vaccine. A wide range of immunological-informatics techniques were utilized to develop a construct that efficiently stimulated cellular and humoral immune responses. The vaccine was produced with 31 epitopes, a TLR4 agonist termed RpfE that acts as an adjuvant, secretion boosters, subcellular trafficking structures, and linkers. It was determined that this suggested vaccine would cover 98.9 percent of the population, making it widely available. We, furthermore, carried out an immunological simulation of the vaccine illustrating the active and stable responses from innate and adaptive immune cells, the memory cells remained active for up to 350 days after vaccine injection, whereas the antigen was excreted from the body within 24 hours. Docking performed with TLR-4 and TLR-3 showed significant interaction with –11.9kcal/mol and –18.2kcal/mol-1 respectively. Molecular dynamics simulations further validated the vaccine’s stability, with a dissociation constant of 1.7E-11 for the TLR3-vaccine complex and 5.8E-11 for the TLR4-vaccine complex. Lastly, codon optimization was carried out to guarantee that the designed mRNA construct would be translated into the host successfully. This vaccine adaptation, if tested in-vitro, would be efficacious and potent as predicted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1VaccinologyToll-Like Receptor 4EpitopesMolecular Dynamics SimulationImmunityMolecular Docking SimulationEpitopes, T-LymphocyteComputational BiologyEpitopes, B-LymphocytemRNA Vaccines

Substanzen

Toll-Like Receptor 4EpitopesEpitopes, T-LymphocyteEpitopes, B-LymphocytemRNA Vaccines

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Life Sciences, University of Central Punjab, Lahore-54590, Pakistan.
  • Department of Agriculture University of Ioannina Arta Greece 47100.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
  • Ministry of Health Kingdom of Saudi Arabia Riyadh.

Zitieren

APA

Naveed, M., Ali, U., Aziz, T., Rasool, M. J., Ijaz, A., Alharbi, M., Alharbi, M. E., Alshammari, A., & Alasmari, A. F. (2023). A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_6696

Vancouver

Naveed M, Ali U, Aziz T, Rasool MJ, Ijaz A, Alharbi M, et al. A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1. Acta Biochimica Polonica. 2023. doi:10.18388/abp.2020_6696

BibTeX
@article{Naveed2023,
  author = {Naveed, Muhammad and Ali, Urooj and Aziz, Tariq and Rasool, Muhammad Junaid and Ijaz, Adil and Alharbi, Metab and Alharbi, Mousa Essa and Alshammari, Abdulrahman and Alasmari, Abdullah F},
  title = {A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1},
  journal = {Acta Biochimica Polonica},
  year = {2023},
  doi = {10.18388/abp.2020_6696}
}
Kostenlos starten →